Inductive matrix completion for predicting adverse drug reactions (ADRs) integrating drug-target interactions

Chemometrics and Intelligent Laboratory Systems

Volumn 144, Issue , 2015, Pages 71-79

  Li, Rong ^a   Dong, Yongcheng ^a   Kuang, Qifan ^a   Wu, Yiming ^a   Li, Yizhou ^a   Zhu, Min ^a   Li, Menglong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adverse drug reactions; Drug; Inductive matrix completion; Singleton; Target

Indexed keywords

GEMCITABINE; PEMETREXED;

ADVERSE DRUG REACTION; ALLERGIC REACTION; ARTICLE; CHEMICAL STRUCTURE; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DRUG INTERACTION; DRUG TARGETING; HETEROGENEOUS NETWORK MODEL; INDUCTIVE MATRIX COMPLETION ALGORITHM; KERNEL METHOD; MEASUREMENT PRECISION; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOM WALKERS WITH RESTART ON HETEROGENEOUS NETWORK; VALIDATION PROCESS;

EID: 84927760644     PISSN: 01697439     EISSN: 18733239     Source Type: Journal    
DOI: 10.1016/j.chemolab.2015.03.013     Document Type: Article

References (47)

1. Edwards I.R., Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000, 356:1255-1259.
2. Baber N. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Br. J. Clin. Pharmacol. 1994, 37:401-404.
3. Whitebread S., Hamon J., Bojanic D., Urban L. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discov. Today 2005, 10:1421-1433.
4. Liu M., Wu Y., Chen Y., Sun J., Zhao Z., Chen X.-w., Matheny M.E., Xu H. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J. Am. Med. Inform. Assoc. 2012, 19:E28-E35.
5. Huang L.-C., Wu X., Chen J.Y. Predicting adverse side effects of drugs. BMC Genomics 2011, 12:S11.
6. Lin J., Kuang Q., Li Y., Zhang Y., Sun J., Ding Z., Li M. Prediction of adverse drug reactions by a network based external link prediction method. Anal. Methods 2013, 5:6120-6127.
7. Scheiber J., Jenkins J.L., Sukuru S.C.K., Bender A., Mikhailov D., Milik M., Azzaoui K., Whitebread S., Hamon J., Urban L., Glick M., Davies J.W. Mapping adverse drug reactions in chemical space. J. Med. Chem. 2009, 52:3103-3107.
8. Xie L., Li J., Xie L., Bourne P.E. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput. Biol. 2009, 5:e1000387.
9. Ji Z.L., Wang Y., Yu L., Han L.Y., Zheng C.J., Chen Y.Z. In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect prediction. Toxicol. Lett. 2006, 164:104-112.
10. Lounkine E., Keiser M.J., Whitebread S., Mikhailov D., Hamon J., Jenkins J.L., Lavan P., Weber E., Doak A.K., Cote S., Shoichet B.K., Urban L. Large-scale prediction and testing of drug activity on side-effect targets. Nature 2012, 486:361-367.
11. Ballesteros J., Palczewski K. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr. Opin. Drug Discov. Dev. 2001, 4:561-574.
12. Cami A., Arnold A., Manzi S., Reis B. Predicting adverse drug events using pharmacological network models. Sci. Transl. Med. 2011, 3.
13. Kuang Q., Wang M., Li R., Dong Y., Li Y., Li M. A systematic investigation of computation models for predicting adverse drug reactions (ADRs). PLoS One 2014, 9:e105889.
14. Singh-Blom U.M., Natarajan N., Tewari A., Woods J.O., Dhillon I.S., Marcotte E.M. Prediction and validation of gene-disease associations using methods inspired by social network analyses. PLoS One 2013, 8.
15. Wu X., Jiang R., Zhang M.Q., Li S. Network-based global inference of human disease genes. Mol. Syst. Biol. 2008, 4.
16. Koehler S., Bauer S., Horn D., Robinson P.N. Walking the interactome for prioritization of candidate disease genes. Am. J. Hum. Genet. 2008, 82:949-958.
17. Vanunu O., Magger O., Ruppin E., Shlomi T., Sharan R. Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol. 2010, 6.
18. Mordelet F., Vert J.-P. ProDiGe: prioritization of disease genes with multitask machine learning from positive and unlabeled examples. BMC Bioinforma. 2011, 12:389.
19. Li Y., Patra J.C. Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network. Bioinformatics 2010, 26:1219-1224.
20. Wang W., Yang S., Zhang X., Li J. Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics 2014, 30:2923-2930.
21. Schein A.I., Popescul A., Ungar L.H., Pennock D.M. Methods and metrics for cold-start recommendations. Proceedings of the 25th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval 2002, 253-260. ACM.
22. Jain P., Dhillon I.S. Provable Inductive Matrix Completion 2013, arXiv, (preprint arXiv:1306.0626).
23. Natarajan N., Dhillon I.S. Inductive matrix completion for predicting gene-disease associations. Bioinformatics 2014, 30:60-68.
24. FAERS website:. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/.
25. Brown E.G., Wood L., Wood S. The Medical Dictionary for Regulatory Activities (MedDRA). Drug Saf. 1999, 20:109-117.
26. Fescharek R., Kübler J., Elsasser U., Frank M., Güthlein P. Medical Dictionary for Regulatory Activities (MedDRA). Int. J. Pharm. Med. 2004, 18:259-269.
27. Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36:D901-D906.
28. Consortium U. The universal protein resource (UniProt). Nucleic Acids Res. 2008, 36:D190-D195.
29. Johnson C.R. Matrix Completion Problems: A Survey 1990, 171-198. Matrix Theory and Applications, Providence, RI.
30. Yu H.-F., Jain P., Kar P., Dhillon I.S. Large-scale Multi-label Learning with Missing Labels 2013, arXiv, (preprint arXiv:1307.5101).
31. van Laarhoven T., Nabuurs S.B., Marchiori E. Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics 2011, 27:3036-3043.
32. Rifkin R., Yeo G., Poggio T. Regularized least-squares classification. NATO Sci. Ser. Ser. III Comput. Syst. Sci. 2003, 190:131-154.
33. Raymond R., Kashima H. Fast and scalable algorithms for semi-supervised link prediction on static and dynamic graphs. Mach. Learn. Knowl. Discov. Databases III 2010, 6323:131-147.
34. Xia Z., Wu L.-Y., Zhou X., Wong S.T.C. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces. BMC Syst. Biol. 2010, 4.
35. Bertrand D., Chng K.R., Sherbaf F.G., Kiesel A., Chia B.K., Sia Y.Y., Huang S.K., Hoon D.S., Liu E.T., Hillmer A. Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles. Nucleic Acids Res. 2015, gku1393.
36. Bleakley K., Yamanishi Y. Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 2009, 25:2397-2403.
37. Yamanishi Y., Araki M., Gutteridge A., Honda W., Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 2008, 24:I232-I240.
38. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006, 34:D354-D357.
39. Hattori M., Okuno Y., Goto S., Kanehisa M. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. J. Am. Chem. Soc. 2003, 125:11853-11865.
40. Singhal A. Modern information retrieval: a brief overview. IEEE Data Eng. Bull. 2001, 24:35-43.
41. Lipkus A.H. A proof of the triangle inequality for the Tanimoto distance. J. Math. Chem. 1999, 26:263-265.
42. Lin D. An information-theoretic definition of similarity, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98) 1998, 296-304.
43. Zhao S., Li S. Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification. PLoS One 2010, 5.
44. Smith T.F., Waterman M.S. Identification of common molecular subsequences. J. Mol. Biol. 1981, 147:195-197.
45. Tamaki M., Konno Y., Kobayashi Y., Takeda M., Itoga M., Moritoki Y., Oyamada H., Kayaba H., Chihara J., Ueki S. Expression and functional roles of G-protein-coupled estrogen receptor (GPER) in human eosinophils. Immunol. Lett. 2014, 160:72-78.
46. Antunes A.M.M., Godinho A.L.A., Martins I.L., Oliveira M.C., Gomes R.A., Coelho A.V., Beland F.A., Marques M.M. Protein adducts as prospective biomarkers of nevirapine toxicity. Chem. Res. Toxicol. 2010, 23:1714-1725.
47. Jiang Y.P., Li Y.Z., Kuang Q.F., Ye L., Wu Y.M., Yang L.J., Li M.L. Predicting putative adverse drug reaction related proteins based on network topological properties. Anal. Methods 2014, 6:2692-2698.